New Breast Cancer Pill Offers Patients Precious Extra Time

A newly approved breast cancer drug is offering hope and more time to patients with advanced, incurable disease. The pill, called capivasertib, is now being funded by the NHS in England and has already helped some women live years longer than expected. One patient, Linda Kelly, credits the treatment with giving her nearly four extra years to travel, garden, and plan new adventures. The drug works by targeting a protein that fuels cancer growth, slowing disease progression and reducing the need for chemotherapy.

In clinical trials, capivasertib significantly delayed cancer growth and shrank tumors in nearly a quarter of patients. Experts say it’s one of the most effective advanced cancer drugs they’ve seen and a major step forward in targeted therapy. For thousands of patients, this pill means not just more time—but a better quality of life.

PrevPreviousDedication to Girlguiding Spans Six Decades

NextElephants Show Remarkable Act of ProtectionNext

Recent Articles

The 98th Academy Awards May Be The Most Exciting In Years

March 15, 2026

This is it. The 98th Academy Awards are upon us, and if you’re not buzzing with anticipation, you haven’t been paying attention. This year’s race has everything: a genuine underdog story, a record-shattering frontrunner, and zero certainty about who walks away with the big prize. At the center of it

Artist Builds Reinterpretation of Mona Lisa From 100,000 Pieces Of Trash

March 15, 2026

Standing four stories tall on the side of an apartment building in El Salvador, a massive new mural is stopping everyone who walks by dead in their tracks, and not just because of its enormous size. The artwork is a reimagined Mona Lisa with a distinctly Latin American face, and

The World’s Tiniest Pacemaker Ever Made That Dissolves

March 15, 2026

For the small percent of babies born with a heart defect who need a pacemaker in the fragile days after surgery, the current solution involves wires, a device strapped to the outside of the chest, and a removal procedure risky enough that it has killed patients. A team of engineers